Which intervention would be included in a plan of care to limit the development of hyperbilirubinemia in the breast-fed neonate?

Choice A rationale Phototherapy is a treatment for established, significant hyperbilirubinemia, not a preventative measure to limit its development. Instituting it immediately without indications for severe jaundice is unnecessary. Furthermore, delaying or interrupting frequent feeding, which is necessary for bilirubin excretion, could actually worsen the bilirubin elevation. Choice B rationale Substitution of formula for breast milk is a measure sometimes used to manage established breast milk jaundice, a late-onset issue, or to temporarily break the enterohepatic circulation cycle in severe cases. However, formula substitution is not a primary preventative intervention and is typically discouraged due to the numerous benefits of breast-feeding. Choice C rationale Obtaining transcutaneous bilirubin levels every six hours is a monitoring strategy used to detect and track hyperbilirubinemia, not a physical intervention to limit its development. While necessary for assessment, it does not address the physiological mechanisms causing the bilirubin elevation in the neonate. Normal total bilirubin levels for a full-term infant on day one are typically less than 6 mg/dL. Choice D rationale Frequent and effective breast-feeding (8-12 times in 24 hours) promotes adequate intake and stimulates peristalsis. This increased gut motility encourages the early and frequent passage of stool (meconium), which facilitates the excretion of bilirubin from the body, thereby reducing the enterohepatic recirculation and limiting the development of hyperbilirubinemia.